| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 02/07/2013 | US20130035284 Small-molecule inhibitors of dengue and west nile virus proteases |
| 02/07/2013 | US20130035283 Engineered opsonin for pathogen detection and treatment |
| 02/07/2013 | US20130035235 Polyurethane dispersions for sealing the teats of the mammary glands in milking animals |
| 02/07/2013 | US20130034618 Compositions for treating the integument |
| 02/07/2013 | US20130034597 Orally bioavailable peptide drug compositions and methods thereof |
| 02/07/2013 | US20130034586 Avirulent oncolytic herpes simplex virus strains engineered to counter the innate host response |
| 02/07/2013 | US20130034585 Bovine Herpes Virus Vaccine With Multiple Mutations |
| 02/07/2013 | US20130034584 Agent for use in the topical or local treatment of cervical dysplasias |
| 02/07/2013 | US20130034582 Reverse genetics methods for virus rescue |
| 02/07/2013 | US20130034580 Novel formulations which stabilize and inhibit precipitation of immunogenic compositions |
| 02/07/2013 | US20130034578 Recombinant multimeric influenza proteins |
| 02/07/2013 | US20130034577 Methods and Compositions for Vaccination Comprising Nucleic Acid and/or Polypeptide Sequences of Chlamydia |
| 02/07/2013 | US20130034576 Novel adenovirus isolated from titi monkeys |
| 02/07/2013 | US20130034575 Method for identification, isolation and production of antigens to a specific pathogen |
| 02/07/2013 | US20130034569 Il-18 receptor antigen binding proteins |
| 02/07/2013 | US20130034564 Anti-rsv g protein antibodies |
| 02/07/2013 | US20130034560 Recombinant proteins for use in vaccine, antibodies against said proteins, and diagnostic and therapeutic methods including the same |
| 02/07/2013 | US20130034556 Free hexasaccharide isolated from several campylobacter species |
| 02/07/2013 | US20130034549 Combination therapy for treating breast cancer |
| 02/07/2013 | US20130034543 Modulating xrn1 |
| 02/07/2013 | US20130034542 Cold treatment |
| 02/07/2013 | US20130034537 Simultaneous co-treatment of physical and mental symptoms related to severe mental disorders by a specially fermented soy formulation (fsww08) |
| 02/07/2013 | US20130034529 Natural compositions and methods of promoting wound healing |
| 02/07/2013 | US20130034522 Therapies for treating hepatitis c virus infection |
| 02/07/2013 | US20130034521 1'-substituted carba-nucleoside analogs for antiviral treatment |
| 02/07/2013 | US20130034520 Hepatitis C Virus Inhibitors |
| 02/07/2013 | US20130034519 Organic compounds and their uses |
| 02/07/2013 | US20130034507 Chlorine Dioxide Treatment for Biological Tissue |
| 02/07/2013 | US20130034500 Cationic Steroid Antimicrobial Compositions and Methods of Use |
| 02/07/2013 | US20130034492 Class I Anti-CEA Antibodies and Uses Thereof |
| 02/07/2013 | CA2844054A1 Inhibitors of influenza viruses replication |
| 02/07/2013 | CA2843908A1 Oligosaccharides and oligosaccharide-protein conjugates derived from clostridium difficile polysaccaride ps-i, methods of synthesis and uses thereof, in particular as vaccines anddiagnostic tools |
| 02/07/2013 | CA2843836A1 Uracil derivative and use thereof for medical purposes |
| 02/07/2013 | CA2843643A1 Compositions and methods for the treatment of hiv |
| 02/07/2013 | CA2843495A1 Hcv immunotherapy |
| 02/07/2013 | CA2843383A1 Amidine compound or salt thereof |
| 02/07/2013 | CA2843274A1 Synthetic nanocarriers that generate humoral and cytotoxic t lymphocyte (ctl) immune responses |
| 02/07/2013 | CA2842872A1 Recombinant swine influenza virus and uses thereof |
| 02/07/2013 | CA2842362A1 Hydrazide containing nuclear transport modulators and uses thereof |
| 02/06/2013 | EP2554550A1 Method for inhibiting hiv replication in mammal and human cells |
| 02/06/2013 | EP2554549A1 Oligosaccharides and oligosaccharides-protein conjugates derived from clostridium difficile polysaccharide PS-I, methods of synthesis and uses thereof, in particular as vaccines and diagnostic tools |
| 02/06/2013 | EP2552963A1 Humanized anti cxcr4 antibodies for the treatment of cancer |
| 02/06/2013 | EP2552958A2 Monoclonal antibody directed against the p17 protein of hiv, capable of neutralising the binding of p17 to the p17 receptor (p17r) |
| 02/06/2013 | EP2552933A1 Purine nucleoside phosphoramidate |
| 02/06/2013 | EP2552931A2 Stereoselective synthesis of phosphorus containing actives |
| 02/06/2013 | EP2552930A2 Nucleoside phosphoramidates |
| 02/06/2013 | EP2552923A1 Macrocyclic integrase inhibitors |
| 02/06/2013 | EP2552915A1 Compounds and method for treatment of hiv |
| 02/06/2013 | EP2552902A1 Non-nucleoside reverse transcriptase inhibitors |
| 02/06/2013 | EP2552893A1 Antibacterial isoquinolin-3-ylurea derivatives |
| 02/06/2013 | EP2552890A1 Polycyclic tetracycline compounds |
| 02/06/2013 | EP2552485A1 Full-length immunoglobulins of the igg isotvpe capable of recognizing a heterosubtvpe neutralizing epitope on the hemagglutinin stem region and their use as anti-influenza medicament |
| 02/06/2013 | EP2552480A1 Hiv vaccine |
| 02/06/2013 | EP2552479A1 Influenza virus vaccines and uses thereof |
| 02/06/2013 | EP2552458A1 Injectable dendrimer hydrogel nanoparticles |
| 02/06/2013 | EP2552445A1 Opioid receptor antagonist (naltrexone) for use in treating herpes zoster disease |
| 02/06/2013 | EP2552440A1 Novel combination and use |
| 02/06/2013 | EP2552434A2 Peptides and their use |
| 02/06/2013 | EP2552431A1 Carvacrol/thymol composition for the treatment of salmonid rickettsial septicemia and infectious salmon anemia |
| 02/06/2013 | EP2552429A1 Combination therapy comprising a ccr5 antagonist, a hiv-1 protease inhibitor and a pharmacokinetic enhancer |
| 02/06/2013 | EP2552426A2 Intravaginal drug delivery device |
| 02/06/2013 | EP2552203A1 Compounds and pharmaceutical compositions for the treatment of viral infections |
| 02/06/2013 | EP2514761A9 Crystal of recombinant interferon with altered spatial configuration, three-dimensional structure and uses thereof |
| 02/06/2013 | CN102918053A Recombinant proteins for use in vaccine, antibodies against said proteins, and diagnostic and therapeutic methods including the same |
| 02/06/2013 | CN102918049A Fused tricyclic silyl compounds and methods of use thereof for the treatment of viral diseases |
| 02/06/2013 | CN102918048A Cephem compound having catechol group |
| 02/06/2013 | CN102918047A Cephem compound having pseudo-catechol group |
| 02/06/2013 | CN102917726A Interferon analogs |
| 02/06/2013 | CN102917724A Pea protein peptides with anti helicobacter pylori activity |
| 02/06/2013 | CN102917712A Nail discoloration and fungus treatment |
| 02/06/2013 | CN102917706A Composition for treating chronic hepatitis B, containing clevudine and adefovir dipivoxil |
| 02/06/2013 | CN102917702A Zinc-containing compositions for the treatment of diseases, illnesses and syndromes associated with exposure to pore forming toxins |
| 02/06/2013 | CN102911988A Preparation method of broad spectrum antimicrobial peptide |
| 02/06/2013 | CN102911987A Cells of which genome is modified |
| 02/06/2013 | CN102911944A Amphioxus intracellular signal transduction protein as well as expression genes and application thereof |
| 02/06/2013 | CN102911943A Chicken Cathelicidins antibacterial peptide and preparation method and application for same |
| 02/06/2013 | CN102911940A Small ribonucleic acid interference molecule for specifically inhibiting NK (Natural Killer) cell receptor KIR3DL1 and application of small ribonucleic acid interference molecule |
| 02/06/2013 | CN102911910A Human embryo lung fibroblast strain and method for using human embryo lung fibroblast strain for producing hand-foot-mouth viral vaccine |
| 02/06/2013 | CN102911899A Proteus mirabilis and application thereof in suppression of biofilm and detoxification |
| 02/06/2013 | CN102911812A Materia medica medicated soap composition and preparation method thereof |
| 02/06/2013 | CN102911285A Process for refining group C/Y/W135 meningococcal polysaccharides |
| 02/06/2013 | CN102911267A TB/HIV (tuberculosis/human immunodeficiency virus) antigen peptide bispecific TCR (T cell receptor) as well recombinant retroviral vector and application thereof |
| 02/06/2013 | CN102911257A Cyclic lipopeptide antibiotic and preparation and application thereof |
| 02/06/2013 | CN102911254A HCV (hepatitis C virus) protease inhibitor |
| 02/06/2013 | CN102911226A Erythromycin derivative and preparation method and applications thereof |
| 02/06/2013 | CN102911191A Preparation method for ethanol 2-hydroxyl naphthaldehyde thiosemicarbazone o-phenanthroline metal complex |
| 02/06/2013 | CN102911189A Salicylaldehyde azine schiff base transition metal compound and application thereof |
| 02/06/2013 | CN102911166A Polymorphic And Other Crystalline Forms of Cis-FTC |
| 02/06/2013 | CN102911165A Polymorphic and other crystalline forms of cis-FTC |
| 02/06/2013 | CN102911161A 病毒聚合酶抑制剂 Viral polymerase inhibitors |
| 02/06/2013 | CN102911124A Hydroxy-pyrimidone compound and preparation method and application thereof |
| 02/06/2013 | CN102911110A N, N-disubstituted-N'-phthaloyl group-1, 3-diamine derivative and preparation method thereof |
| 02/06/2013 | CN102911103A 1-(3, N, N-disubstituted amino group propyl group)-pyrrolidone derivative and preparation method thereof |
| 02/06/2013 | CN102911040A Sesquiterpenoids from marine fungi source as well as preparation method and application thereof |
| 02/06/2013 | CN102908633A Multifunctional gold and silver core-shell nanoparticles and preparation method |
| 02/06/2013 | CN102908625A Chicken Newcastle disease and avian infectious bronchitis bivalent live vaccine heat-resistant protective agent and preparation process thereof |
| 02/06/2013 | CN102908619A Preparation method of egg yolk antibody injection for treating porcine respiratory syndrome |
| 02/06/2013 | CN102908618A Preparation method of divalent inactivated vaccines for duck virus hepatitis |
| 02/06/2013 | CN102908617A Porcine reproductive and respiratory syndrome virus M protein and CD40L fusion vaccine and preparation method |
| 02/06/2013 | CN102908616A Riemerella anatipestifer tervalent inactivated vaccine and preparation method thereof |